JAMONY
Jacob Asset Management of New York’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $184K | Buy |
4,850
+4,416
| +1,018% | +$168K | 0.26% | 56 |
|
|
2023
Q2 | $39.5K | Sell |
434
-110
| -20% | -$10K | 0.04% | 65 |
|
|
2023
Q1 | $35.9K | Sell |
544
-3,500
| -87% | -$231K | 0.04% | 64 |
|
|
2022
Q4 | $209K | Buy |
4,044
+1,385
| +52% | +$71.6K | 0.25% | 55 |
|
|
2022
Q3 | $182K | Buy |
2,659
+1,005
| +61% | +$68.8K | 0.2% | 60 |
|
|
2022
Q2 | $75K | Sell |
1,654
-1,645
| -50% | -$74.6K | 0.08% | 70 |
|
|
2022
Q1 | $168K | Sell |
3,299
-9,556
| -74% | -$487K | 0.1% | 71 |
|
|
2021
Q4 | $608K | Sell |
12,855
-3,233
| -20% | -$153K | 0.27% | 59 |
|
|
2021
Q3 | $530K | Buy |
16,088
+2,888
| +22% | +$95.1K | 0.19% | 65 |
|
|
2021
Q2 | $834K | Buy |
13,200
+3,200
| +32% | +$202K | 0.28% | 67 |
|
|
2021
Q1 | $429K | Hold |
10,000
| – | – | 0.17% | 72 |
|
|
2020
Q4 | $572K | Buy |
+10,000
| New | +$572K | 0.43% | 45 |
|